The workflow runs in five steps: an online intake questionnaire, review by a licensed prescriber affiliated with the platform, a fill by a partner pharmacy, shipment on a repeating schedule tied to billing, and support split between a clinical queue and an account queue. Almost every recurring review theme traces back to one of those five.
Asynchronous intake, and what it does and does not include
Most women’s telehealth plans begin with a written questionnaire rather than a live appointment. The customer submits history, current medications, and measurements, and a prescriber reviews the file and decides. Some cases prompt a follow-up message or a video call, and some are declined. This store-and-forward pattern is what makes the model fast and cheap.
What it does not include by default is a physical examination. Published work on direct-to-consumer telemedicine identifies that as the model’s central trade-off: assessment depth is compressed in exchange for access, and platforms differ in how much assessment they keep. A questionnaire that asks about pregnancy status, thyroid and pancreatic history, eating disorder history, and every current medication is doing more clinical work than one that asks for height, weight, and a card number.
Who actually writes the prescription
Telehealth companies do not prescribe. Prescriptions come from clinicians licensed in the patient’s state, generally working through an affiliated professional entity rather than being employed by the commercial brand. That structure exists because the corporate practice of medicine rules in many states separate the business from the clinical decision.
The practical checks that follow are simple. A prescriber’s name and license can be confirmed with the state board. The pharmacy filling the prescription can be named on request, and for a compounded preparation that name carries more weight, because compounded products are not FDA-approved and the agency has not reviewed the specific preparation for safety, effectiveness, or manufacturing quality.
How refills are scheduled, and why that matters
Refills on these plans are pushed rather than pulled. A charge on the billing date triggers a fill and a shipment, instead of the customer requesting each one. That is why billing questions and supply questions arrive together in reviews: on a plan like this they are the same event described from two directions.
Three dates need to agree for a cycle to run smoothly: the charge date, the shipping date, and the date the current supply runs out. When they drift apart, a customer either receives medication early and accumulates it, or runs short before the next fill clears. The question worth asking a physician-supervised treatment provider is when the next charge falls relative to the next shipment, and whether a cycle can be shifted without canceling the plan.
| Step | Who owns it | Common failure | How it appears in reviews |
|---|---|---|---|
| Intake questionnaire | The platform | Screening too shallow for the medication | Praise for speed, or unease about how easy it was |
| Prescriber review | Licensed clinician in the patient’s state | Decision arrives after payment is taken | Charged before approval |
| Pharmacy fill | Partner or affiliated pharmacy | Sourcing not disclosed to the patient | Questions about what arrived in the box |
| Shipment | Carrier, cold chain where needed | Delay leaves a gap in supply | Missed dose complaints |
| Refill cycle | The platform, on the billing date | Charge and supply dates drift apart | Unexpected charge, or arriving too early |
| Support | Split clinical and account queues | Message routed to the wrong queue | Slow or unanswered replies |
Why support feels split, because it is
A clinical message about a side effect and an account message about a charge go to different teams with different training and different response targets. Customers do not see the boundary and often send both through whichever channel is nearest, which is the single most common cause of a message that appears to be ignored.
Two habits reduce that risk. Send clinical and billing questions separately, each through its own channel, and ask for the published response window for each so a delay can be measured against something. Where a program handles multiple categories under one login, naming the service line at the top of the message helps as well.
Where onboarding quality shows up later
The instructions given at the first shipment matter more than they appear to. A poison control case series documented administration errors with compounded semaglutide, including confusion over measurement units, and guidance written for prescribers on compounded semaglutide stresses clear counseling for exactly that reason. A program that supplies written and video instructions, plus a named contact for a dosing question, is doing something a lower-touch program is not.
Behavioral support is the other differentiator. In the STEP 3 trial, semaglutide was studied alongside intensive behavioral therapy, and the structured support was part of the intervention rather than an extra. Whether a plan includes real coaching or a set of automated emails is worth establishing before the first charge, since it is one of the few things a customer can verify in advance.
None of this surfaces in a star rating, so the practical move is comparing a few named providers on what they actually publish about sourcing and support. The GLP-1 field a Hers shopper is weighing includes Ro, Henry Meds, and Hims and Hers, the direct manufacturer option LillyDirect, and providers such as HealthRX that document the GLP-1 medications they dispense along with the counseling that comes with a first shipment. Those published details answer more than a review thread can.
Frequently asked questions
Is a video visit required to get a prescription?
Not always. Many plans work asynchronously, with a prescriber reviewing a written questionnaire and requesting a call only when the file needs clarification. State rules and the specific medication both influence this, and some categories carry stricter requirements than others.
Can a refill date be moved without canceling?
Usually, if the account offers a delay or pause function or the support team can shift the cycle. Because the charge triggers the fill, moving the charge moves the shipment. Confirming in writing which cycle the change applies to avoids the most common misunderstanding.
What should be asked about the pharmacy?
Its name, its state licensure, and whether the product is an FDA-approved brand-name medication or a compounded preparation. For compounded products the answer carries more weight, because no agency review of that specific preparation for safety, effectiveness, or manufacturing quality has taken place.
Why do clinical replies arrive faster than billing replies?
Because they are different teams. Clinical messaging is usually staffed to a shorter target for safety reasons, while account and refund questions sit in a general queue. Sending a billing question through the clinical channel typically means it gets forwarded rather than answered, adding a full cycle of delay.
What is worth verifying first-hand before signing up?
Five things: the prescriber’s state license, the pharmacy name, whether the product is approved or compounded, the price at the strength likely to be reached, and the refill and cancellation dates. All five are answerable in writing before payment, and none of them can be settled by reading reviews.
